BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22046579)

  • 1. Capsaicin-sensitive afferentation represents an indifferent defensive pathway from eradication in patients with H. pylori gastritis.
    Lakner L; Dömötör A; Tóth C; Szabó IL; Meczker A; Hajós R; Kereskai L; Szekeres G; Döbrönte Z; Mózsik G
    World J Gastrointest Pharmacol Ther; 2011 Oct; 2(5):36-41. PubMed ID: 22046579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capsaicin as new orally applicable gastroprotective and therapeutic drug alone or in combination with nonsteroidal anti-inflammatory drugs in healthy human subjects and in patients.
    Mózsik G
    Prog Drug Res; 2014; 68():209-58. PubMed ID: 24941671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Participation of capsaicin-sensitive afferent nerves in the gastric mucosa of patients with Helicobacter pylori-positive or-negative chronic gastritis.
    Dömötör A; Kereskay L; Szekeres G; Hunyady B; Szolcsányi J; Mózsik G
    Dig Dis Sci; 2007 Feb; 52(2):411-7. PubMed ID: 17195120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study.
    Kyzekova J; Mour J
    Hepatogastroenterology; 1999; 46(27):2048-56. PubMed ID: 10430396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Helicobacter pylori infection and gastric mucosal histological features of gastric ulcer patients with chronic gastritis patients.
    Zhang C; Yamada N; Wu YL; Wen M; Matsuhisa T; Matsukura N
    World J Gastroenterol; 2005 Feb; 11(7):976-81. PubMed ID: 15742399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis.
    Nardone G; Staibano S; Rocco A; Mezza E; D'armiento FP; Insabato L; Coppola A; Salvatore G; Lucariello A; Figura N; De Rosa G; Budillon G
    Gut; 1999 Jun; 44(6):789-99. PubMed ID: 10323879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
    Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
    Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy.
    Konturek PC; Rembiasz K; Konturek SJ; Stachura J; Bielanski W; Galuschka K; Karcz D; Hahn EG
    Dig Dis Sci; 2003 Jan; 48(1):36-46. PubMed ID: 12645788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there any relationship between functional dyspepsia and chronic gastritis associated with Helicobacter pylori infection?
    Kyzekové J; Arlt J; Arltová M
    Hepatogastroenterology; 2001; 48(38):594-602. PubMed ID: 11379362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection.
    McCarthy CJ; Crofford LJ; Greenson J; Scheiman JM
    Am J Gastroenterol; 1999 May; 94(5):1218-23. PubMed ID: 10235197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in apoptosis and decrease in ornithine decarboxylase activity of the gastric mucosa in patients with atrophic gastritis and gastric ulcer after successful eradication of Helicobacter pylori.
    Hirasawa R; Tatsuta M; Iishi H; Yano H; Baba M; Uedo N; Sakai N
    Am J Gastroenterol; 1999 Sep; 94(9):2398-402. PubMed ID: 10483998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative damage of the gastric mucosa in Helicobacter pylori positive chronic atrophic and nonatrophic gastritis, before and after eradication.
    Iacopini F; Consolazio A; Bosco D; Marcheggiano A; Bella A; Pica R; Paoluzi OA; Crispino P; Rivera M; Mottolese M; Nardi F; Paoluzi P
    Helicobacter; 2003; 8(5):503-12. PubMed ID: 14535997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of mutant type-p53 products in H pylori-associated chronic gastritis.
    Kodama M; Murakami K; Okimoto T; Sato R; Watanabe K; Fujioka T
    World J Gastroenterol; 2007 Mar; 13(10):1541-6. PubMed ID: 17461446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gastric mucosa lesions in gastric ulcer disease. Initial study and 1-year follow-up after Helicobacter pylori eradication].
    Bermejo F; Boixeda D; Gisbert JP; Sanz JM; Defarges V; Alvarez Calatayud G; Martín de Argila C
    Gastroenterol Hepatol; 2000; 23(6):269-74. PubMed ID: 15324621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Course of histological lesions of the gastric mucosa after eradication of H. pylori in patients with duodenal ulcer. Initial study and 6-month follow-up].
    Gisbert JP; Boixeda D; Alvarez Baleriola I; Redondo C; De Rafael L; Martín de Argila C; Hernández Ranz F
    Rev Esp Enferm Dig; 1995 Apr; 87(4):281-7. PubMed ID: 7794634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety.
    Kuipers EJ; Uyterlinde AM; Peña AS; Hazenberg HJ; Bloemena E; Lindeman J; Klinkenberg-Knol EC; Meuwissen SG
    Am J Gastroenterol; 1995 Sep; 90(9):1401-6. PubMed ID: 7661157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin and D cells in patients with gastritis in the course of Helicobacter pylori eradication: a six-month, follow-up study.
    Milutinovic AS; Todorovic V; Milosavljevic T; Micev M; Spuran M; Drndarevic N
    Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):755-66. PubMed ID: 12811306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor and transforming growth factor alpha in duodenal ulcer and non-ulcer dyspepsia patients before and after Helicobacter pylori eradication.
    Konturek PC; Bobrzynski A; Konturek SJ; Bielanski W; Faller G; Kirchner T; Hahn EG
    Scand J Gastroenterol; 1998 Feb; 33(2):143-51. PubMed ID: 9517524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-mediated neural dysfunction in a murine model of chronic Helicobacter pylori infection.
    Bercík P; De Giorgio R; Blennerhassett P; Verdú EF; Barbara G; Collins SM
    Gastroenterology; 2002 Oct; 123(4):1205-15. PubMed ID: 12360482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre and post eradication gastric inflammation in Helicobacter pylori-associated duodenal ulcer.
    Kumar D; Dhar A; Dattagupta S; Ahuja V; Mathur M; Sharma MP
    Indian J Gastroenterol; 2002; 21(1):7-10. PubMed ID: 11871846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.